Progress in breast cancer individualized management through multidisciplinary monitoring        SHEN Kun-wei, LI Hong-wei. Breast Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025,China
Corresponding author: SHEN Kun-wei, E-mail: kwshen@medmail.com.cn
Abstract    Multiple disciplines are involved in the management of breast cancer in many aspects，including prevention, screening and early diagnosis, local and systemic therapies. Recently, multidisciplinary management,including multidisciplinary clinic and multidisciplinary conference, has become the standard care of breast cancer. In the era of evidence-based medicine, biomarkers such as estrogen receptor, progesterone receptor, and HER-2 status together with traditional clinicopathologic factors are used to further divide breast cancers into different molecular sub-groups. Individualized approach is the best optimized choice for breast cancer management. Clinicians are using genomic techniques to further investigate prognostic and therapeutic biomarkers aiming to obstain efficacy benefit with reduced toxicity.